Our daily NVIDIA analysis breaks down critical levels, market trends, and insights for today’s trading session.
1 extracted signal · 1 resolved · 0 still active
Wicked Stocks04 Nov 2025, 03:02 UTC
AI-generated source summary
The analysis for NVDA stock predicts a bullish trend over the next 2 weeks, targeting the upper 220s. A weekly containment level is established at 202.22, with a soft intra-day pivot point at 214.48. The rising channel top is currently around 227.38. The overall long-term outlook remains positive above 181.20, with potential to reach levels around 219.64 to 228.94 based on ABC wave counts. A close below 200.56 could invalidate the bullish sentiment, while a drop to the low 180s would need to happen before the end of the year to challenge to the long term overall positive outcome.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Wicked Stocks
Tesla Stock Price Analysis | Top $TSLA Levels To Watch for July 31st, 2026
#TSLA MAY BOUNCE FIRST... THEN FALL TO $227 #Tesla #daytrading
Tesla Stock Price Analysis | Top $TSLA Levels To Watch for July 30th, 2026
#TSLA BOUNCED FROM $300... BUT IS IT A TRAP? #Tesla #daytrading
Tesla Stock Price Analysis | Top $TSLA Levels To Watch for July 29th, 2026
#TSLA $300 TEST IS ALMOST HERE #Tesla #daytrading
Wicked Stocks
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
